Health ❯Public Health

Opioid Crisis

Fentanyl Substance Abuse Addiction Fentanyl Epidemic Opioid Addiction Addiction Treatment Drug Addiction Fentanyl Overdoses OxyContin Opioid Epidemic Fentanyl Issues Fentanyl Crisis Prescription Drugs Opioid Abuse Drug Overdoses Drug Policy Pain Management Drug Trafficking Government Strategy Government Strategies Pharmaceuticals Fentanyl Trade Research Studies Lawsuits Legislation Opioid Overdose Deaths Opioid Overdose Fentanyl Addiction Deceptive Marketing Strategies Oxycodone Naloxone Distribution Safe Injection Sites Legislative Response Addiction Response Coalition Addiction Epidemic Prescription Opioids Fentanyl Overdose Addiction Prevention Drug Overdose Medetomidine Fentanyl Production Opioid Funds Victims Treatment and Prevention OxyCotin Victims of Opioids Victims Compensation Drug Manufacturing Drug Epidemic Prescription-Opioid Overdoses Victim Advocacy Pharmaceutical Company Funding Children Drug Enforcement

Purdue Pharma Proposes $7.4 Billion Settlement Plan for Opioid Crisis Lawsuits

The plan includes up to $7 billion from the Sackler family, victim compensation, and Purdue's transformation into a public benefit company.

Trump Links Tariffs on Canada, Mexico, and China to Fentanyl Crisis

Mexico Deploys 10,000 Troops to Combat Fentanyl Trafficking at U.S. Border

Canada's Liberal Party Prepares to Select New Leader and Prime Minister

House Passes Bill to Permanently Classify Fentanyl as a Schedule I Drug

DOJ Sues Walgreens Over Millions of Allegedly Illegal Opioid Prescriptions

Ex-McKinsey Partner Pleads Guilty to Obstructing Opioid Investigation

Indian Chemical Companies and Executive Charged in U.S. Fentanyl Precursor Trafficking Case

UnitedHealthcare CEO's Murder Highlights Deep Frustration with U.S. Health Insurance System

DOJ Sues CVS for Allegedly Filling Unlawful Opioid Prescriptions

Congress Advances Sweeping Health Bill Targeting PBM Practices

Ohio Supreme Court Overturns $650 Million Opioid Judgment Against Pharmacies

Ontario Auditor General Report Criticizes $2.2B Ontario Place Redevelopment Process

RNC Speakers Link Fentanyl Crisis to Biden's Border Policies

Purdue Pharma Granted 60-Day Pause to Renegotiate Opioid Settlement

New Compound Boosts Naloxone's Effectiveness Against Opioid Overdoses

Supreme Court Ruling Overturns Purdue Pharma's $6 Billion Settlement

New Animal Tranquilizer Medetomidine Fuels Overdose Surge in Midwest

Justice Department Investigates McKinsey's Role in Opioid Crisis

Biden-Harris Administration Launches Nationwide Initiative to Combat Overdose Crisis